Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Cancer targeting gene-viro-therapy for pancreatic cancer using oncolytic adenovirus ZD55-IL-24 in immune-competent mice.

He B, Huang X, Liu X, Xu B.

Mol Biol Rep. 2013 Sep;40(9):5397-405. doi: 10.1007/s11033-013-2638-8.

PMID:
23666064
2.

An armed oncolytic adenovirus ZD55-IL-24 combined with ADM or DDP demonstrated enhanced antitumor effect in lung cancer.

Zhong S, Yu D, Wang Y, Qiu S, Wu S, Liu XY.

Acta Oncol. 2010;49(1):91-9. doi: 10.3109/02841860903246557.

PMID:
19734998
3.

The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer.

Zhao L, Dong A, Gu J, Liu Z, Zhang Y, Zhang W, Wang Y, He L, Qian C, Qian Q, Liu X.

Cancer Gene Ther. 2006 Nov;13(11):1011-22.

PMID:
16799468
4.

Synergistic suppression effect on tumor growth of hepatocellular carcinoma by combining oncolytic adenovirus carrying XAF1 with cisplatin.

Ma B, Wang Y, Zhou X, Huang P, Zhang R, Liu T, Cui C, Liu X, Wang Y.

J Cancer Res Clin Oncol. 2015 Mar;141(3):419-29. doi: 10.1007/s00432-014-1835-8.

PMID:
25240826
5.

Cancer targeting gene-viro-therapy specific for liver cancer by α-fetoprotein-controlled oncolytic adenovirus expression of SOCS3 and IL-24.

Cao X, Wei R, Liu X, Zeng Y, Huang H, Ding M, Zhang K, Liu XY.

Acta Biochim Biophys Sin (Shanghai). 2011 Oct;43(10):813-21. doi: 10.1093/abbs/gmr071.

PMID:
21835849
6.

Enhanced antitumor efficacy of a novel oncolytic adenovirus combined with temozolomide in the treatment of melanoma in vivo.

Jiang G, Sun C, Li RH, Wei ZP, Zheng JN, Liu YQ.

J Cancer Res Clin Oncol. 2015 Jan;141(1):75-85. doi: 10.1007/s00432-014-1763-7.

PMID:
25103017
7.

Enhancement of tumor cell death by combining cisplatin with an oncolytic adenovirus carrying MDA-7/IL-24.

Wu YM, Zhang KJ, Yue XT, Wang YQ, Yang Y, Li GC, Li N, Wang YG.

Acta Pharmacol Sin. 2009 Apr;30(4):467-77. doi: 10.1038/aps.2009.16.

8.

One potential oncolytic adenovirus expressing Lipocalin-2 for colorectal cancer therapy.

Xu B, Zheng WY, Feng JF, Huang XY, Ge HY.

Cancer Biother Radiopharm. 2013 Jun;28(5):415-22. doi: 10.1089/cbr.2012.1352.

PMID:
23464854
9.

Targeting lung cancer stem-like cells with TRAIL gene armed oncolytic adenovirus.

Yang Y, Xu H, Huang W, Ding M, Xiao J, Yang D, Li H, Liu XY, Chu L.

J Cell Mol Med. 2015 May;19(5):915-23. doi: 10.1111/jcmm.12397.

10.

Potent antitumor activity of oncolytic adenovirus expressing mda-7/IL-24 for colorectal cancer.

Zhao L, Gu J, Dong A, Zhang Y, Zhong L, He L, Wang Y, Zhang J, Zhang Z, Huiwang J, Qian Q, Qian C, Liu X.

Hum Gene Ther. 2005 Jul;16(7):845-58.

PMID:
16000066
11.

Oncolytic adenovirus expressing interleukin-18 induces significant antitumor effects against melanoma in mice through inhibition of angiogenesis.

Zheng JN, Pei DS, Mao LJ, Liu XY, Sun FH, Zhang BF, Liu YQ, Liu JJ, Li W, Han D.

Cancer Gene Ther. 2010 Jan;17(1):28-36. doi: 10.1038/cgt.2009.38.

PMID:
19498459
12.

Synergistic antitumor effect of TRAIL and IL-24 with complete eradication of hepatoma in the CTGVT-DG strategy.

Cai Y, Liu X, Huang W, Zhang K, Liu XY.

Acta Biochim Biophys Sin (Shanghai). 2012 Jun;44(6):535-43. doi: 10.1093/abbs/gms031.

PMID:
22635106
13.

Gene-viro-therapy targeting liver cancer by a dual-regulated oncolytic adenoviral vector harboring IL-24 and TRAIL.

Liu X, Cao X, Wei R, Cai Y, Li H, Gui J, Zhong D, Liu XY, Huang K.

Cancer Gene Ther. 2012 Jan;19(1):49-57. doi: 10.1038/cgt.2011.67.

PMID:
21979578
14.

The antitumor efficacy of IL-24 mediated by E1A and E1B triple regulated oncolytic adenovirus.

Xiao LL, Wu YM, Qian J, Tan Y, Xie GL, Zhang KJ, Wang YG, Jia XY, Liu XY.

Cancer Biol Ther. 2010 Aug 1;10(3):242-50.

PMID:
20574150
15.

Effects of G250 promoter controlled conditionally replicative adenovirus expressing Ki67-siRNA on renal cancer cell.

Liu J, Fang L, Cheng Q, Li L, Su C, Zhang B, Pei D, Yang J, Li W, Zheng J.

Cancer Sci. 2012 Oct;103(10):1880-8. doi: 10.1111/j.1349-7006.2012.02380.x.

16.

A new oncolytic adenoviral vector carrying dual tumour suppressor genes shows potent anti-tumour effect.

Liu XR, Cai Y, Cao X, Wei RC, Li HL, Zhou XM, Zhang KJ, Wu S, Qian QJ, Cheng B, Huang K, Liu XY.

J Cell Mol Med. 2012 Jun;16(6):1298-309. doi: 10.1111/j.1582-4934.2011.01396.x.

17.

Cancer targeting Gene-Viro-Therapy of liver carcinoma by dual-regulated oncolytic adenovirus armed with TRAIL gene.

Cao X, Yang M, Wei RC, Zeng Y, Gu JF, Huang WD, Yang DQ, Li HL, Ding M, Wei N, Zhang KJ, Xu B, Liu XR, Qian QJ, Liu XY.

Gene Ther. 2011 Aug;18(8):765-77. doi: 10.1038/gt.2011.16.

PMID:
21412282
18.

Combination of ZD55-MnSOD therapy with 5-FU enhances antitumor efficacy in colorectal cancer.

Zhang Y, Qin X, Zhang Y, Zhao L, Wang Y, Liu X, Yao L.

J Cancer Res Clin Oncol. 2008 Feb;134(2):219-26.

PMID:
17632733
19.

Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor-related apoptosis-inducing ligand gene virotherapy.

Zhang Y, Gu J, Zhao L, He L, Qian W, Wang J, Wang Y, Qian Q, Qian C, Wu J, Liu XY.

Cancer Res. 2006 Apr 15;66(8):4291-8.

20.

Acetylcholinesterase overexpression mediated by oncolytic adenovirus exhibited potent anti-tumor effect.

Xu H, Shen Z, Xiao J, Yang Y, Huang W, Zhou Z, Shen J, Zhu Y, Liu XY, Chu L.

BMC Cancer. 2014 Sep 15;14:668. doi: 10.1186/1471-2407-14-668.

Items per page

Supplemental Content

Support Center